Tuesday , April 24 2018
Home / Production Assistant, Diabetes In Control (page 32)

Production Assistant, Diabetes In Control

Minimizing Side Effects

Test Your Knowledge

Your patient has been newly diagnosed with type 2 diabetes (A1C 7.7%) and you have prescribed metformin. Metformin should be titrated to minimize which side effect? A. Rebound hyperglycemia B. Reactive hypoglycemia C. Weight gain D. Gastrointestinal-side effects Follow the link to see the answer.

Read More »

BG Monitoring Recommendations

How often do you recommend to your type 2 patients who are not on insulin to monitor their blood sugars daily? 1. Once a day 2. Twice a day 3. More than twice a day 4. Once a week or Less than daily Follow the link to share your response.

Read More »

Diabetes Tracker

Are you tired of having to write down your Blood Sugar test results? Would you like a way to get ride of the pen and pencil? Well try Diabetes Tracker. We take the K.I.S.S. approach.

Read More »

Aug. 22, 2017

Too often when we see patients we arbitrarily give them a goal A1c. Most of us don’t make every person strive for 5.7, but we sometimes forget to find out what the patient really thinks they can accomplish. This week we combined information from Dr. Karl Nadolsky and our Medical Editor to …

Read More »

The Power of Numbers

A disaster can be considered many different things to different people. For some it could mean developing type 2 diabetes rather than preventing or delaying it. If you watch our expert video series you will hear our Publisher ask many of our experts, “Whether or not you have diabetes, what would you like your A1C to be?” As our expert, Dr. Karl Nadolsky said, he’d like his to be in the normal range, ~ 5%. This is not unusual for us as health care providers to want and work towards a normal A1C, that is, depending on age, and risk for complications of hypoglycemia.

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #84: Measuring Insulin Action In Vivo

The wonders of lactate: Very recently, our laboratory has made a major improvement in the use of the minimal model to assess insulin sensitivity and evaluate its importance in metabolic control. During the FSIGT, as it is practiced, there is initially a large increase in glucose concentration, due to the glucose injection, there is an endogenous finite insulin response in normal individuals, and the insulin is then increased again at 20 min after the exogenous insulin injection. We considered the question of the fate of the injected glucose before the secondary insulin injection. In the absence of a large increase in insulin, much of the glucose is disposed by an insulin-independent mechanism, a process we termed “glucose effectiveness.”

Read More »